UNC Lineberger Comprehensive Cancer Center is on the forefront of innovative chimeric antigen T-cell, or CAR-T, immunotherapy. Hear from Dr. Jonathan Serody as he explains how he is designing, developing and delivering CAR-T therapies to treat cancers that fail to respond to standard treatments.